Heat Map: The Prioritization of Anti-Counterfeiting Measures in Developing Countries

Developing countries are the worst affected from counterfeit pharmaceuticals, regulatory structures are weaker and measurement and oversight is difficult. According to the World Health Organization, an estimated 1 in 10 medical products in low- and middle-income countries is substandard or falsified. This heat map specifically focuses in on the largest counterfeiting markets: Africa, China, and India. Download this map to learn about the latest advancements developing countries have taken in 2017 to combat anti-counterfeiting and which country needs to start making it a priority.